DiaMedica Therapeutics (DMAC) Institutional Ownership $6.11 +0.18 (+3.04%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$6.14 +0.03 (+0.56%) As of 08/22/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for DiaMedica Therapeutics (NASDAQ:DMAC)CurrentInstitutional OwnershipPercentage10.12%Number ofInstitutional Buyers(last 12 months)33TotalInstitutional Inflows(last 12 months)$8.16MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$881.73K Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DMAC Institutional Buying and Selling by Quarter DiaMedica Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 BNP Paribas Financial Markets18,882$74K0.0%+24.4%0.037% 8/15/2025 Bank of America Corp DE8,497$33K0.0%+3,710.3%0.016% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.14,425$56K0.0%N/A0.028% 8/13/2025 Marshall Wace LLP61,719$241K0.0%+227.8%0.119% 8/13/2025 Invesco Ltd.13,885$54K0.0%N/A0.027% 8/13/2025 New York State Common Retirement Fund26,300$103K0.0%N/A0.051% 8/12/2025 JPMorgan Chase & Co.12,483$49K0.0%N/A0.024% 8/8/2025 Intech Investment Management LLC14,415$56K0.0%N/A0.028% 8/8/2025 Police & Firemen s Retirement System of New Jersey7,441$29K0.0%N/A0.014% 8/8/2025 Geode Capital Management LLC630,148$2.46M0.0%+99.6%1.219% Get the Latest News and Ratings for DMAC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DiaMedica Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2025 World Investment Advisors31,975$125K0.0%+24.7%0.075% 7/16/2025 Perigon Wealth Management LLC53,000$207K0.0%N/A0.124% 6/27/2025 Goldman Sachs Group Inc.121,802$462K0.0%+76.7%0.284% 5/19/2025 Jane Street Group LLC100,669$382K0.0%+138.5%0.235% 5/16/2025 Goldman Sachs Group Inc.121,802$462K0.0%+76.7%0.284% 5/15/2025 First Manhattan CO. LLC.606,435$2.30M0.0%-27.7%1.415% 5/15/2025 Royal Bank of Canada155,031$588K0.0%+46,879.1%0.362% 4/29/2025 World Investment Advisors25,650$97K0.0%+17.0%0.060% 4/18/2025 Cornerstone Wealth Management LLC16,250$62K0.0%N/A0.038% 2/17/2025 OMERS ADMINISTRATION Corp22,500$122K0.0%N/A0.053% 2/17/2025 Millennium Management LLC84,829$461K0.0%+151.8%0.198% 2/17/2025 Balyasny Asset Management L.P.14,581$79K0.0%N/A0.034% 2/17/2025 683 Capital Management LLC76,116$413K0.0%N/A0.178% 2/14/2025 Jane Street Group LLC42,212$229K0.0%N/A0.099% 2/14/2025 Schonfeld Strategic Advisors LLC26,097$142K0.0%N/A0.061% 2/14/2025 Northern Trust Corp180,192$978K0.0%+49.8%0.421% 2/14/2025 Susquehanna International Group LLP374,845$2.04M0.0%+269.5%0.877% 2/14/2025 Dimensional Fund Advisors LP19,339$105K0.0%+14.0%0.045% 2/13/2025 Barclays PLC27,726$151K0.0%N/A0.065% 2/13/2025 Raymond James Financial Inc.15,267$83K0.0%N/A0.036% 2/13/2025 Bank of Montreal Can15,560$84K0.0%N/A0.036% 2/12/2025 World Investment Advisors21,915$119K0.0%N/A0.051% 2/12/2025 Paragon Associates & Paragon Associates II Joint Venture514,784$2.80M6.5%+6.7%1.204% 2/11/2025 LPL Financial LLC152,000$825K0.0%+8.2%0.355% 2/6/2025 Raymond James Financial Inc.15,267$83K0.0%N/A0.036% 2/6/2025 Meridian Wealth Management LLC27,216$148K0.0%N/A0.064% 2/4/2025 Y Intercept Hong Kong Ltd14,973$81K0.0%N/A0.035% 1/30/2025 Blue Trust Inc.69,122$375K0.0%+56.2%0.162% 1/22/2025 Blue Trust Inc.69,122$375K0.0%+56.2%0.162% 11/16/2024 Geode Capital Management LLC306,958$1.29M0.0%+29.6%0.718% BREAKING: The House just passed 3 pro-crypto bills! (Ad)THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Discover the under-the-radar project I believe will skyrocket as a result.11/15/2024 Point72 Asia Singapore Pte. Ltd.9,498$40K0.0%N/A0.022% 10/18/2024 Blue Trust Inc.44,247$185K0.0%N/A0.104% 8/16/2024 Magnolia Capital Advisors LLC29,500$87K0.0%N/A0.069% 5/10/2024 Vanguard Group Inc.1,013,522$2.81M0.0%+26.3%2.670% 2/15/2024 Paragon Associates & Paragon Associates II Joint Venture500,000$1.42M3.3%+6.4%1.318% 2/7/2024 Avantax Advisory Services Inc.12,500$36K0.0%N/A0.033% 11/15/2023 Stonebridge Capital Advisors LLC20,000$52K0.0%N/A0.053% 11/13/2023 EAM Investors LLC212,512$548K0.1%-21.4%0.560% 11/9/2023 Bleichroeder LP222,317$574K0.1%-24.4%0.586% 11/1/2023Jacob Asset Management of New York LLC168,730$435K0.6%-15.1%0.445% 8/30/2023 Cooperman Leon G875,993$3.78M0.2%+0.9%2.308% 8/10/2023Jacob Asset Management of New York LLC198,730$859K1.0%-15.0%0.738% 8/2/2023 Catalyst Financial Partners LLC36,267$157K0.1%+44.4%0.135% 4/11/2023 Catalyst Financial Partners LLC25,110$38K0.0%+73.5%0.095% 5/12/2022Jacob Asset Management of New York LLC265,000$663K0.4%-3.6%1.002% 2/15/2022 Stonepine Capital Management LLC1,194,670$4.46M2.0%+620.7%4.519% 11/15/2021 Marshall Wace LLP10,031$40K0.0%-93.6%0.053% 11/15/2021 Manatuck Hill Partners LLC273,100$1.10M0.4%-52.1%1.454% 11/12/2021 Stonepine Capital Management LLC165,775$665K0.3%-60.5%0.882% 11/12/2021 Jump Financial LLC18,300$73K0.0%N/A0.097% 11/9/2021BlackRock Inc.55,970$225K0.0%-8.6%0.298% 8/25/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/16/2021 State Street Corp30,217$134K0.0%N/A0.161% 8/16/2021Corriente Advisors LLC203,641$906K0.5%-76.6%1.084% 8/16/2021 Marshall Wace LLP155,662$693K0.0%+104.9%0.829% 8/13/2021 Renaissance Technologies LLC94,100$419K0.0%-38.5%0.501% 8/13/2021 Geode Capital Management LLC133,569$594K0.0%+4.0%0.711% 8/13/2021 Vanguard Group Inc.786,266$3.50M0.0%-7.1%4.185% 8/12/2021 Trexquant Investment LP17,019$76K0.0%N/A0.091% 8/12/2021 Dimensional Fund Advisors LP14,074$63K0.0%N/A0.075% 8/12/2021 JPMorgan Chase & Co.8,299$37K0.0%N/A0.044% 8/12/2021 Bank of Montreal Can142,846$694K0.0%+36.7%0.760% (Data available from 1/1/2016 forward) DMAC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMAC shares? During the previous two years, 42 institutional investors and hedge funds held shares of DiaMedica Therapeutics. The most heavily invested institutionals were Cooperman Leon G ($3.78M), Vanguard Group Inc. ($2.81M), Paragon Associates & Paragon Associates II Joint Venture ($2.80M), Geode Capital Management LLC ($2.46M), First Manhattan CO. LLC. ($2.30M), Susquehanna International Group LLP ($2.04M), and Northern Trust Corp ($978K).Learn more on DiaMedica Therapeutics' institutional investors. What percentage of DiaMedica Therapeutics' stock is owned by institutional investors? 10.12% of DiaMedica Therapeutics' stock is owned by institutional investors. Learn more on DMAC's institutional investor holdings. Which institutional investors have been buying DiaMedica Therapeutics' stock? Of the 38 institutional investors that purchased DiaMedica Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($384.48K), Susquehanna International Group LLP ($273.40K), Vanguard Group Inc. ($211.35K), Royal Bank of Canada ($154.70K), Goldman Sachs Group Inc. ($105.71K), Jane Street Group LLC ($100.67K), and Blue Trust Inc. ($94.00K). How much institutional buying is happening at DiaMedica Therapeutics? Institutional investors have bought a total of 1,779,886 shares in the last 24 months. This purchase volume represents approximately $8.16M in transactions. Which of DiaMedica Therapeutics' major shareholders have been selling company stock? The following institutional investors have sold DiaMedica Therapeutics stock in the last 24 months: First Manhattan CO. LLC. ($232.65K). How much institutional selling is happening at DiaMedica Therapeutics? Institutional investors have sold a total of 232,646 shares in the last 24 months. This volume of shares sold represents approximately $881.73K in transactions. Related Companies Phibro Animal Health Major Shareholders Xeris Biopharma Major Shareholders CureVac Major Shareholders Enliven Therapeutics Major Shareholders Calliditas Therapeutics AB (publ) Major Shareholders Collegium Pharmaceutical Major Shareholders Intellia Therapeutics Major Shareholders Pharvaris Major Shareholders Structure Therapeutics Major Shareholders Tilray Brands Major Shareholders This page (NASDAQ:DMAC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.